Chloroquine Phosphate 250mg — brands & medicines in Pakistan
Pakistan mein Chloroquine Phosphate 250mg ke 1 brands available hain. Drug class: Antimalarial / Disease-Modifying Antirheumatic Drug (DMARD). Neeche se koi bhi brand select karein aur uses, dosage, side effects aur price dekhein.
Quick Answer
Chloroquine Phosphate 250mg is a antimalarial / disease-modifying antirheumatic drug (dmard) used in Pakistan for Malaria prophylaxis (prevention), Malaria treatment (Plasmodium vivax and P. malariae), Rheumatoid arthritis. Available as 1 brand. Prescription required. Always confirm dose with a doctor or pharmacist.
What is Chloroquine Phosphate 250mg?
Chloroquine Phosphate 250mg is a antimalarial / disease-modifying antirheumatic drug (dmard) used in Pakistan for a range of medical conditions. Doctors and pharmacists in Pakistan recognize Chloroquine Phosphate 250mg under multiple brand names — currently 1 listed on PakVita (1 tablet). The information below is a synthesis from DRAP-registered medicine entries, BNF, and WHO Essential Medicines references.
Common indications
- Malaria prophylaxis (prevention)
- Malaria treatment (Plasmodium vivax and P. malariae)
- Rheumatoid arthritis
- Systemic lupus erythematosus (SLE)
Indication and dose vary by medical condition, age, weight, and other factors. Always confirm with a qualified doctor or pharmacist before starting.
Typical dosage
As prescribed by your doctor based on indication
This is a general adult guidance pattern based on the manufacturer's label for one of the Chloroquine Phosphate 250mg brands listed below. Children, elderly patients, pregnant women, and people with kidney or liver impairment usually need different dosing — confirm with your doctor.
Side effects
Common (usually mild)
- Nausea and vomiting
- Headache
- Dizziness
Serious — stop and see a doctor
- Retinopathy (irreversible eye damage with long-term use)
- QT interval prolongation and cardiac arrhythmia
- Blood disorders (rare)
Important warnings
- Do not use Chloroquine Tablet if you are allergic to chloroquine or 4-aminoquinolines
- Regular eye examinations required for long-term use — chloroquine can cause retinopathy
- Avoid in patients with psoriasis or porphyria
Conditions treated
Chloroquine Phosphate 250mg brands in Pakistan (1)
Click any brand to see full uses, dosage, side effects, prices, and warnings.
Frequently asked questions
What is Chloroquine Phosphate 250mg used for in Pakistan?
Chloroquine Phosphate 250mg is commonly used for Malaria prophylaxis (prevention), Malaria treatment (Plasmodium vivax and P. malariae), Rheumatoid arthritis, Systemic lupus erythematosus (SLE). It belongs to the antimalarial / disease-modifying antirheumatic drug (dmard) drug class.
What is the typical dosage of Chloroquine Phosphate 250mg?
Typical adult dosing is described by manufacturers as: "As prescribed by your doctor based on indication". Always confirm dose, duration, and timing with a qualified doctor or pharmacist — dose depends on indication, weight, age, kidney/liver function, and other medications.
What are the common side effects of Chloroquine Phosphate 250mg?
Common side effects include Nausea and vomiting, Headache, Dizziness. Most are mild and resolve as the body adjusts. Stop the medicine and contact a doctor if side effects are severe, persistent, or include allergic symptoms (rash, swelling, breathing difficulty).
When should I stop Chloroquine Phosphate 250mg and see a doctor?
Stop Chloroquine Phosphate 250mg and seek urgent medical care if you experience: Retinopathy (irreversible eye damage with long-term use); QT interval prolongation and cardiac arrhythmia; Blood disorders (rare). These are serious signs that need immediate attention.
Is Chloroquine Phosphate 250mg available without a prescription in Pakistan?
Prescription required.
What brands of Chloroquine Phosphate 250mg are available in Pakistan?
1 brand of Chloroquine Phosphate 250mg is listed on PakVita: 1 tablet. Browse the brand list below and click any name for prices, dosage, and full information.
Sources
- DRAP Registered Drug Products Database — Drug Regulatory Authority of Pakistan
- British National Formulary (BNF) — BMJ Group & Pharmaceutical Press
- WHO Model List of Essential Medicines, 23rd ed. — World Health Organization